tiprankstipranks
Trending News
More News >
QuantumPharm, Inc. (HK:2228)
:2228
Hong Kong Market
Advertisement

QuantumPharm, Inc. (2228) Stock Statistics & Valuation Metrics

Compare
5 Followers

Total Valuation

QuantumPharm, Inc. has a market cap or net worth of HK$26.50B. The enterprise value is HK$17.30B.
Market CapHK$26.50B
Enterprise ValueHK$17.30B

Share Statistics

QuantumPharm, Inc. has 4,017,001,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,017,001,700
Owned by Insiders
Owned by Institutions

Financial Efficiency

QuantumPharm, Inc.’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -16.45%.
Return on Equity (ROE)-0.38
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-16.45%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee329.34K
Profits Per Employee-1.87M
Employee Count809
Asset Turnover0.06
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of QuantumPharm, Inc. is ―. QuantumPharm, Inc.’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.72
Price to FCF0.00
Price to Operating Cash Flow-24.90
PEG Ratio

Income Statement

In the last 12 months, QuantumPharm, Inc. had revenue of 266.43M and earned -1.52B in profits. Earnings per share was -0.79.
Revenue266.43M
Gross Profit123.43M
Operating Income-684.21M
Pretax Income-1.51B
Net Income-1.52B
EBITDA-631.38M
Earnings Per Share (EPS)-0.79

Cash Flow

In the last 12 months, operating cash flow was -299.29M and capital expenditures -32.02M, giving a free cash flow of -331.31M billion.
Operating Cash Flow-299.29M
Free Cash Flow-331.31M
Free Cash Flow per Share-0.08

Dividends & Yields

QuantumPharm, Inc. pays an annual dividend of HK$0.007, resulting in a dividend yield of ―
Dividend Per ShareHK$0.007
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.76
52-Week Price Change13.01%
50-Day Moving Average5.63
200-Day Moving Average5.78
Relative Strength Index (RSI)63.73
Average Volume (3m)80.89M

Important Dates

QuantumPharm, Inc. upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend DateJun 13, 2016

Financial Position

QuantumPharm, Inc. as a current ratio of 11.85, with Debt / Equity ratio of 3.75%
Current Ratio11.85
Quick Ratio11.85
Debt to Market Cap<0.01
Net Debt to EBITDA1.61
Interest Coverage Ratio-101.26

Taxes

In the past 12 months, QuantumPharm, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

QuantumPharm, Inc. EV to EBITDA ratio is -15.47, with an EV/FCF ratio of -18.19.
EV to Sales36.65
EV to EBITDA-15.47
EV to Free Cash Flow-18.19
EV to Operating Cash Flow-20.40

Balance Sheet

QuantumPharm, Inc. has HK$3.39B in cash and marketable securities with HK$163.57M in debt, giving a net cash position of -HK$3.22B billion.
Cash & Marketable SecuritiesHK$3.39B
Total DebtHK$163.57M
Net Cash-HK$3.22B
Net Cash Per Share-HK$0.80
Tangible Book Value Per ShareHK$2.08

Margins

Gross margin is 45.94%, with operating margin of -256.80%, and net profit margin of -569.23%.
Gross Margin45.94%
Operating Margin-256.80%
Pretax Margin-568.57%
Net Profit Margin-569.23%
EBITDA Margin-236.98%
EBIT Margin-268.27%

Analyst Forecast

The average price target for QuantumPharm, Inc. is HK$6.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$6.00
Price Target Upside-3.07% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast50.10%
EPS Growth Forecast-212.76%

Scores

Smart Score5
AI Score56
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis